Francesc Miro Mur I am a researcher in the lab of "Systemic Autoimmune Diseases" of the VHIR. It is a recent operating team focused in the research of cellular and molecular mechanisms underlying the pathology of autoimmune diseases such as antiphospholipid syndrome. Previously, as an awarded Biomedical Researcher (PERIS-ICS) I studied the role of immune cells in modulating the inflammation during the acute phase of stroke. Instituciones de las que forman parte Investigador/a principal Enfermedades Sistémicas Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Francesc Miro Mur LinkedIn Twitter Orcid Email Instituciones de las que forman parte Investigador/a principal Enfermedades Sistémicas Vall Hebron Institut de Recerca I am a researcher in the lab of "Systemic Autoimmune Diseases" of the VHIR. It is a recent operating team focused in the research of cellular and molecular mechanisms underlying the pathology of autoimmune diseases such as antiphospholipid syndrome. Previously, as an awarded Biomedical Researcher (PERIS-ICS) I studied the role of immune cells in modulating the inflammation during the acute phase of stroke.
As a biochemist and cell biologist I started my career in basic research and sharing time as a biochemist lecturer at Universitat Autònoma de Barcelona. Regulation of cell function and activity by protein phosphorylation were the aims of my research. I moved to Paris to carry out my postdoctoral research career. My first postdoc was at CNRS-CEA to study the cell cycle progression and apoptosis under the control of p53 tumour suppressor.. In my second postdoc at Institut Curie I made a change starting a research career on immunology, looking into cellular and functional interaction between T lymphocytes and dendritic cells. It was during this amazing stage I collaborated with clinicians and saw the benefits of translational research. I spent two years at Cibbim working as a team leader in projects about molecular mechanisms of inflammation driving to senescence and about immunological basis of adverse reactions to bioimplants. At IRB I took the opportunity of doing a project in aminoacyl-tRNA synthetases as infectious agents in amebiasis, and also I turned to neuroimmunology and did research in brain ischemia. 1988-1993 BSc in Biology, speciality Biochemistry. UAB, Barcelona 1992-1993 Undergraduate collaborator, Biochem Dept, UAB 1995 Master Fellow, Laboratoire Cancerogénèse Moléculaire, CNRS-Villejuif, France 1996-1999 Ph.D., Biochem Dept, UAB 2000 Postdoc Researcher, Biochem Dept, Universita di Padova, Italy 2000-2003 Lecturer A3.6, Biochem & Mol Biol, UAB 2001-2003 Postdoc. Researcher, Lab Oncogénèse Moléculaire, CEA-CNRS, France 2003-2006 Postdoc Researcher, Cancer & Immunity Lab, Institut Curie, France 2007-2009 Postdoc Researcher, CIBER-nanomedicine, VHIR, Barcelona 2009-2011 Postdoc Researcher, Gene translation Lab, IRB-Barcelona 2011-2016 Postdoc Researcher, IDIBAPS, Barcelona 2017-2019 PERIS Researcher, Hospital Clinic, Barcelona
Proyectos Envejecimiento endotelial y procesos inflamatorios crónicos IP: Francesc Miro Mur Colaboradores: - Entidad financiadora: Fundació de l'Agrupació Mútua Financiación: 15000 Referencia: FAMV/01/2008 Duración: 01/01/2009 - 31/12/2009 Envejecimiento endotelial y sus efectos pleiotrópicos sobre procesos inflamatorios, de la respuesta inmune y angiogénesis IP: Francesc Miro Mur Colaboradores: Jaume Alijotas Reig, Simon Schwartz Navarro Entidad financiadora: Fundación Invest. Médica Mutua Madrileña Financiación: 36000 Referencia: FMMA/05/2008 Duración: 24/09/2008 - 23/09/2011 CIBER: Bioingenieria, biomateriales y nanomedicina IP: - Colaboradores: Manuel López Cano, Jaume Alijotas Reig, Francesc Miro Mur, Eloy Espín Basany Entidad financiadora: CIBER Bioing., Biomateriales y Nanomedicina , BBN Financiación: 480000 Referencia: CB06/01/0012 Duración: 01/01/2007 - 31/12/2010 Paginación Primera página « Página anterior ‹ Página 1 Página actual 2
